Whose population of Bosnia and Herzegovina is affected



[ad_1]

The population of Bosnia and Herzegovina, looking at the anatomical group, spent the most money for drugs for the cardiovascular system (about 112.3 million KM 18.28% of the figure for Business total), then for drugs the tract and metabolism (102.2 million KM 16.65%) and the nervous system (77 million KM 12.53%), confirmed by Feni of the Agency medicines and medical devices from Bosnia and Herzegovina.

  • News
  • Bosnia and Herzegovina


If a therapeutic group is observed, then most of the money is spent on anti-hyperglycemic drugs – 62.3 million KM (10.15%), then drugs treated at the Renin-angiotensin-52 (8.57%), antineoplastic drugs (KM 51 million (8.31%) and antibacterial drugs for systemic use – KM 30.7 million (5.01%).

group included Antineoplastic drugs – 47.2 million KM, followed by insulin and analogues – 40.6, anticoagulants – 28.1, ACE inhibitors – 22.5 million KM. antidepressants are ranked 20th out of the KM 8.6 million spent on drug sales in 2017.

Regarding financial sales, sales of antidepressants rise to 8, 6 million KM, accounting for 1.41% of the total drug business, and less than 2016 where 10 million marks were spent The most financial money was spent in hostels (eschatopram (about 2.4 million KM), followed by paroxetine (2 million) followed by sertraline (1.67 million) and fluoxetine (1 million). , 2 million)

While reductions in consumption (mainly due to the regulation of maximum wholesale drug prices), looking at the packages sold drugs to most drugs, sales have increased, for example for paroxetine increase of 10% – 9% increase, while sertraline was reduced by 13 %.The number of packets of drugs sold is followed by other antidepressants: amitriptyline, venlafaxine, maprotiline and other.

In the four most sold hostels, 883,136 packets of drugs are marketed, while all antidepressants combined 1.1 million packets.

The Medical and Medical Agency of BiH states that the report s emerald for the first half of 2018 is not yet complete, but that the order of consumption of any anatomical, therapeutic or pharmacological group has not changed significantly for several years,.! function

(AP)

[ad_2]
Source link